Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 1.8T | 1.8T | 1.8T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 313.9B | 321.8B | 322.3B |
Other operating expenses | — | 15.5B | 1.1B | 349M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 5.1B | 7.2B | 7.8B |
Other income expense | — | 170.6B | 0 | 0 |
Pretax income | — | 242.3B | 306.3B | 104.8B |
Tax provision | — | 69.3B | 4.1B | 34.3B |
Net income | — | 172.9B | 302.2B | 70.5B |
Basic EPS | 100.6 | — | — | — |
Diluted EPS | 100.6 | — | — | — |
Basic average shares | 2.0B | — | — | — |
Diluted average shares | 2.0B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | 5.4B | 10.3B | 6.6B |
Preferred stock dividends | — | — | — | — |